A survey of the attitudes, beliefs and knowledge about medical cannabis among primary care providers
Tóm tắt
Từ khóa
Tài liệu tham khảo
Pollio A. The name of Cannabis: a short guide for nonbotanists. Cannabis Cannabinoid Res. 2016;1(1):234–8.
Vigil JM, Stith SS, Adams IM, Reeve AP. Associations between medical cannabis and prescription opioid use in chronic pain patients: a preliminary cohort study. PLoS One. 2017;12(11):e0187795.
Public Law: The comprehensive drug abuse prevention and control act of 1970 [ https://legcounsel.house.gov/Comps/91-513.pdf ]. Accessed 15 Jan 2019.
Abuhasira R, Shbiro L, Landschaft Y. Medical use of cannabis and cannabinoids containing products - regulations in Europe and North America. Eur J Intern Med. 2018;49:2–6.
Klieger SB, Gutman A, Allen L, Pacula RL, Ibrahim JK, Burris S. Mapping medical marijuana: state laws regulating patients, product safety, supply chains and dispensaries, 2017. Addiction. 2017;112(12):2206–16.
National Academies of Sciences Engineering and Medicine (U.S.). Committee on the health effects of marijuana: an evidence review and research agenda: the health effects of cannabis and cannabinoids : the current state of evidence and recommendations for research. Washington, DC: the National Academies Press; 2017.
Abrams DI. The therapeutic effects of Cannabis and cannabinoids: an update from the National Academies of sciences, engineering and medicine report. Eur J Intern Med. 2018;49:7–11.
Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K, Ryder S, et al. Cannabinoids for medical use: a systematic review and meta-analysis. JAMA. 2015;313(24):2456–73.
Rong C, Carmona NE, Lee YL, Ragguett RM, Pan Z, Rosenblat JD, Subramaniapillai M, Shekotikhina M, Almatham F, Alageel A, et al. Drug-drug interactions as a result of co-administering Delta(9)-THC and CBD with other psychotropic agents. Expert Opin Drug Saf. 2018;17(1):51–4.
Heng M, McTague MF, Lucas RC, Harris MB, Vrahas MS, Weaver MJ. Patient perceptions of the use of medical marijuana in the treatment of pain after musculoskeletal trauma: a survey of patients at 2 trauma centers in Massachusetts. J Orthop Trauma. 2018;32(1):e25–30.
Mathern GW, Beninsig L, Nehlig A. Fewer specialists support using medical marijuana and CBD in treating epilepsy patients compared with other medical professionals and patients: result of Epilepsia's survey. Epilepsia. 2015;56(1):1–6.
Kondrad E, Reid A. Colorado family physicians' attitudes toward medical marijuana. J Am Board Fam Med. 2013;26(1):52–60.
Andreae MH, Carter GM, Shaparin N, Suslov K, Ellis RJ, Ware MA, Abrams DI, Prasad H, Wilsey B, Indyk D, et al. Inhaled Cannabis for chronic neuropathic pain: a meta-analysis of individual patient data. J Pain. 2015;16(12):1221–32.
McLoughlin BC, Pushpa-Rajah JA, Gillies D, Rathbone J, Variend H, Kalakouti E, Kyprianou K. Cannabis and schizophrenia. Cochrane Database Syst Rev. 2014;(10):CD004837.
MN MEDIC AL CANNABIS PROGRAM UPDATE, OCTOBER 2017 [ http://www.health.state.mn.us/topics/cannabis/about/update1017.pdf ]. Accessed 15 Jan 2019.
Bowen LL, McRae-Clark AL. Therapeutic benefit of smoked Cannabis in randomized placebo-controlled studies. Pharmacotherapy. 2017;38(1):80–5.
MEDICAL MARIJUANA ACCESS IN THE UNITED STATES: A Patient-Focused Analysis of the Patchwork of State Laws [ http://www.safeaccessnow.org/medical_marijuana_access_in_the_usa ]. Accessed 15 Jan 2019.
Meng H, Johnston B, Englesakis M, Moulin DE, Bhatia A. Selective cannabinoids for chronic neuropathic pain: a systematic review and meta-analysis. Anesth Analg. 2017;125(5):1638–52.
Ware JE Jr, Gandek B. Overview of the SF-36 health survey and the international quality of life assessment (IQOLA) project. J Clin Epidemiol. 1998;51(11):903–12.
Hajjaj FM, Salek MS, Basra MK, Finlay AY. Non-clinical influences on clinical decision-making: a major challenge to evidence-based practice. J R Soc Med. 2010;103(5):178–87.
Miller RJ, Miller RE. Is cannabis an effective treatment for joint pain? Clin Exp Rheumatol. 2017;35(Suppl 107(5)):59–67.
Russo EB. Current therapeutic Cannabis controversies and clinical trial design issues. Front Pharmacol. 2016;7:309.
Evanoff AB, Quan T, Dufault C, Awad M, Bierut LJ. Physicians-in-training are not prepared to prescribe medical marijuana. Drug Alcohol Depend. 2017;180:151–5.